Liso-Cel is a type of CAR T-cell therapy — a revolutionary approach that uses a patient's own immune cells to fight cancer.

This study presents a valuable finding on the direct cytotoxic effects of DuoHexaBody-CD37 in diffuse large B-cell lymphoma, mediated via SHP-1 activation and antibody clustering, independent of ...

such as anaplastic large cell lymphoma (ALCL), peripheral T-cell lymphoma (PTCL), and cutaneous T-cell lymphoma (CTCL). Their ability to work effectively in treatment-naive and relapsed or refractory ...

PRESENTED at EBMT 2025 Annual Meeting, a new study explored the long-term effectiveness of chimeric antigen receptor (CAR)-T cell cocktail therapy for patients with relapsed/refractory diffuse large B ...

Precomplexed AFM13-NK cells are more readily able to find and eliminate CD30-positive lymphoma cells. The technique was explored in “Emerging Frontiers in Immunotherapy: The Promise of NK-Cell ...

According to the report, there were 821 attempts to censor library books across all library types in 2024. This is down from the previous year, though still the third-highest number of book ...

As part of its annual report, the ALA unveiled its list of the 10 most “challenged books” of 2024, starting with George M. Johnson’s “All Boys Aren’t Blue,” and also featuring ...

or CAR T cell therapy, where a patient's immune cells are taken out, grown and modified to specifically target certain cancers such as the aggressive lymphoma Cannella had. When he was first ...

As part of its annual report, the ALA unveiled its list of the 10 most “challenged books” of 2024, starting with George M. Johnson's “All Boys Aren't Blue,” and also featuring “Gender ...

I’m guessing his own book, “The War on Warriors: Behind the Betrayal of the Men Who Keep Us Free,” won’t make the cut list. It’s an interesting title, because the act of banning history ...

Following a successful Type B end-of-phase 2 meeting, the FDA has approved the start of a phase 3 trial of linperlisib in peripheral T-cell lymphoma. The FDA has granted clearance to initiate a global ...